725 related articles for article (PubMed ID: 23912973)
21. Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist.
Sato A; Fukuda S
Hypertens Res; 2013 Oct; 36(10):879-84. PubMed ID: 23864056
[TBL] [Abstract][Full Text] [Related]
22. Endocrine arterial hypertension: therapeutic approach in clinical practice.
Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
[TBL] [Abstract][Full Text] [Related]
23. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
Gross E; Rothstein M; Dombek S; Juknis HI
Am J Kidney Dis; 2005 Jul; 46(1):94-101. PubMed ID: 15983962
[TBL] [Abstract][Full Text] [Related]
24. [Renin-angiotensin-aldosterone system inhibition: pharmacologic rationale and evaluations of drug combinations].
Andréjak M; Slama M; Hary L
Therapie; 1998; 53(3):291-300. PubMed ID: 9773129
[TBL] [Abstract][Full Text] [Related]
25. Resistant Hypertension: Which Agent?
Prosser HCG; Azzam O; Schlaich MP
Heart Lung Circ; 2018 Aug; 27(8):911-916. PubMed ID: 29526418
[TBL] [Abstract][Full Text] [Related]
26. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic Issues in treating hypertension in CKD.
Sica DA
Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
[TBL] [Abstract][Full Text] [Related]
28. [Salt sensitive blood pressure and the renin-angiotensin system in hypertension].
Krekels MM; de Leeuw PW
Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2285-9. PubMed ID: 9550812
[TBL] [Abstract][Full Text] [Related]
29. Management of hypertension with fixed-dose triple-combination treatments.
Epstein BJ; Shah NK; Borja-Hart NL
Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
[TBL] [Abstract][Full Text] [Related]
30. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
31. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
[TBL] [Abstract][Full Text] [Related]
32. High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system.
Kamari Y; Shimoni N; Koren F; Peleg E; Sharabi Y; Grossman E
J Hypertens; 2010 Jan; 28(1):95-101. PubMed ID: 19770680
[TBL] [Abstract][Full Text] [Related]
33. Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Azizi M; Perdrix L; Bobrie G; Frank M; Chatellier G; Ménard J; Plouin PF
J Hypertens; 2014 Oct; 32(10):2038-44; discussion 2044. PubMed ID: 24983187
[TBL] [Abstract][Full Text] [Related]
34. Resistant hypertension optimal treatment trial: a randomized controlled trial.
; Krieger EM; Drager LF; Giorgi DM; Krieger JE; Pereira AC; Barreto-Filho JA; da Rocha Nogueira A; Mill JG
Clin Cardiol; 2014 Jan; 37(1):1-6. PubMed ID: 24338935
[TBL] [Abstract][Full Text] [Related]
35. Management of blood pressure in patients with diabetes.
Grossman E; Messerli FH
Am J Hypertens; 2011 Aug; 24(8):863-75. PubMed ID: 21525967
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy in hypertension.
Gorostidi M; de la Sierra A
Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
[TBL] [Abstract][Full Text] [Related]
37. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
[TBL] [Abstract][Full Text] [Related]
38. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP).
McInnis NH; Fodor G; Moy Lum-Kwong M; Leenen FH
Am J Hypertens; 2008 Nov; 21(11):1210-5. PubMed ID: 18772857
[TBL] [Abstract][Full Text] [Related]
40. Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.
Bobrie G; Frank M; Azizi M; Peyrard S; Boutouyrie P; Chatellier G; Laurent S; Menard J; Plouin PF
J Hypertens; 2012 Aug; 30(8):1656-64. PubMed ID: 22728905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
